EPIC Test Compendium Alpha
Welcome to the new Northwell Health Labs Test Directory, please call our Client Services Department at 1-800-472-5757 with any typos, corrections or issues.

NASH FibroSure Plus

Test Catalog Information

Test Catalog Synonyms

EPIC Synonyms Nonalcoholic Fatty Liver Disease
NASHFIBRO
Cerner Primary MnemonicNASH FibroSure Plus
EPIC Display NameNASH FibroSure Plus
Allscripts (AEHR) Order Name

NASH FibroSure Plus

Sunrise Clinical Manager (SCM) Order Name

NASH FibroSure Plus

EPIC Inpatient Orderable Yes
EPIC Outpatient Orderable Yes
Cerner Results FIB A2MACRO
FIB APOA1
FIB GGT
NASHFIBROLT
NASHFIBROSTS
NASHFIBROT
NASHFIBRONS
NASHFIBRONSC
NASHFIBROSC
FIB ALT
FIB HAPTO
FIB SCORING
NASHFIBROSS
NASHFIBROGS
NASHFIBROSG
NASHFIBROCT
NASHFIBROAST
NASHFIBRONG
FIB TBIL
Methodology (LabCorp)
NASHFIBROST
NASHFIBROINT
NASHFIBROCM
NASHFIBROCOM
Clinical Info

This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). Limitations NASH FibroSure® is recommended for patients with suspected nonalcoholic fatty liver disease. It is not recommended for patient with other  liver diseases. It is also not recommended in patients with Gilbert disease, acute hemolysis, acute hepatitis, acute inflammation of the liver, autoimmune  hepatitis, extrahepatic cholestasis, transplant patients, and/or renal insufficiency patients. Any of these clinical situations may lead to inaccurate quantitative  predictions of fibrosis.

Specimen Type

Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube: Red or Gold top tube Specimen: 3.5 mL serum ( 2 mL min) Transport Temperature: Refrigerated Note: Patient should be fasting for at least eight hours Causes for Rejection Gross hemolysis; gross lipemia; improper labeling; nonfasting specimen; patient younger than 14 years of age

Transport Instructions

Refrigerated

Specimen Stability

3 Days Room Temperature or Refrigerated 7 Days Frozen .

Methodology

The analytes tested are performed by FibroSure-Specific methods.

Days Performed

Performing Laboratory

LabCorp

CPT

82172; 82247; 82465; 82947; 82977; 83010; 83883;  84450;  84460;  84478

PDM

1559233

Desired Epic Build NASH FibroSure Plus

Cerner Primary Mnemonic: NASH FibroSure Plus
PDM 1559233
Informatics - WorkgroupChemistry
Synonyms *Nonalcoholic Fatty Liver Disease
NASHFIBRO
Display Name *NASH FibroSure Plus
Order Entry Specimen Sources *
Order Entry Specimen Types
Blood
Specimen Navigator Specimen Types
Specimen Navigator Specimen Sources
Specimen Navigator Short Name
Ordering info (EPIC SmartText)This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). Limitations NASH FibroSure® is recommended for patients with suspected nonalcoholic fatty liver disease. It is not recommended for patient with other  liver diseases. It is also not recommended in patients with Gilbert disease, acute hemolysis, acute hepatitis, acute inflammation of the liver, autoimmune  hepatitis, extrahepatic cholestasis, transplant patients, and/or renal insufficiency patients. Any of these clinical situations may lead to inaccurate quantitative  predictions of fibrosis.
IP Orderable Yes
OP Orderable Yes
AOEs *

AP AOEs
Special History No
Build Comments
Filter *
Procedure Category Change
Cerner Results

Result DescResult displayResult PDM
FIB A2MACRO FIB A2MACRO 5907810G
FIB APOA1 FIB APOA1 5907810I
FIB GGT FIB GGT 5907810K
NASHFIBROLT NASHFIBROLT 1559233Q
NASHFIBROSTS NASHFIBROSTS 1559233U
NASHFIBROT NASHFIBROT 1559233L
NASHFIBRONS NASHFIBRONS 1559233E
NASHFIBRONSC NASHFIBRONSC 1559233P
NASHFIBROSC NASHFIBROSC 1559233A
FIB ALT FIB ALT 5907810L
FIB HAPTO FIB HAPTO 5907810H
FIB SCORING FIB SCORING 5907810N
NASHFIBROSS NASHFIBROSS 1559233C
NASHFIBROGS NASHFIBROGS 1559233K
NASHFIBROSG NASHFIBROSG 1559233D
NASHFIBROCT NASHFIBROCT 1559233J
NASHFIBROAST NASHFIBROAST 1559233I
NASHFIBRONG NASHFIBRONG 1559233F
FIB TBIL FIB TBIL 5907810J
Methodology Methodology (LabCorp) 1559233T
NASHFIBROST NASHFIBROST 1559233B
NASHFIBROINT NASHFIBROINT 1559233M
NASHFIBROCM NASHFIBROCM 1559233S
NASHFIBROCOM NASHFIBROCOM 1559233R

Current Actual EPIC Build as of 10/28/2024

Procedure Id 114160
Pdm 1559233
Order Display Name NASH FibroSure Plus
Procedure Name NASH FIBROSURE
Procedure Master Number LAB10822
Short Procedure Name NASH FIBROSURE
Category Code 1.0
Category Code Record Name LAB BLOOD ORDERABLES
Synonyms NONALCOHOLIC FATTY LIVER DISEASE NASHFIBRO
Clinically Active Yes
Orderable Yes
Performable Yes
Filter Genomics
Reference Link Url https://labs.northwell.edu/epic/test/114160
Ordering Instructions
Default Specimen Type Blood
Specimen Type Pick List Blood
Specimen Type List
Op Specimen Type List
Specimen Source Pick List Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous
Specimen Source Default - Male Blood, Venous
Specimen Source Default - Female Blood, Venous
Specimen Source List
Op Specimen Source List
Ip Lab Test Components For Report
Op Lab Test Components For Report
Order Questions ["3045300170", "3045300171", "3045300173"]
Order Questions Record Name NH IP HOME COLLECT DATE NH IP HOME COLLECT DAYS NH IP HOME COLLECT MEDICALLY NECESSARY
Inpatient Order Questions []
Inpatient Order Questions Record Name
Order Specific Question Override Yes
Inpatient Question Override
Location Restrict List Ip
Location Restrict List Ip Record Name
Location Restrict List Include Ip
Location Restrict List Op
Location Restrict List Op Record Name
Location Restrict List Includes Op
Edp Amb Order Specific Questions Record Name
Edp Ip Order Specific Questions Record Name
Edp Ip Specimen Source Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary
Edp Op Specimen Source
Edp Ip Specimen Type Blood
Edp Op Specimen Type
Derived Edp Ip Buttons S Blood, Central Line Blood, Venous Blood, Capillary Blood, Arterial
Derived Edp Ip Buttons T Blood
Derived Edp Op Buttons S
Derived Edp Op Buttons T
Ip Orderable 1
Op Orderable 1
EPIC OP AOEs

Question IDQuestion NameQuestionResponse TypeResponse ListRequire Response
3045300170 NH IP HOME COLLECT DATE Start Date Date Yes
3045300171 NH IP HOME COLLECT DAYS Days Custom List Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday
Yes
3045300173 NH IP HOME COLLECT MEDICALLY NECESSARY Medically Necessary? Yes/No Yes
EPIC IP AOEs

EPIC Components (results)

Component IDComponent NameBase NameCommon NameExternal NameCerner Result PDM
3047800927 ALPHA 2-MACROGLOBULINS, QN A2MACROGLQN ALPHA 2 MACROGLOBULINS QN 5907810G
3047801148 APOLIPOPROTEIN A-1 APOA1 APOLIPOPROTEIN A 1 5907810I
3047802584 GGT GGT GGT GGT 5907810K
3047803294 LIMITATIONS LIMITA LIMITATIONS 1559233Q
3047806582 STEATOSIS SCORING STEATOSISSC STEATOSIS SCORING 1559233U
3047805676 TRIGLYCERIDES. TRIG TRIGLYCERIDES Triglycerides 1559233L
3047803700 NASH SCORE NASH NASH SCORE 1559233E
3047803701 NASH SCORING NASH NASH SCORING 1559233P
3047805487 FIBROSIS SCORE. FIBROSIS FIBROSIS SCORE 1559233A
3047800973 ALT (SGPT) P5P ALT ALT SGPT P5P 5907810L
5907810H
3047802452 FIBROSIS SCORING: FIBROSISSCR FIBROSIS SCORING 5907810N
3047804816 STEATOSIS SCORE STEATSC STEATOSIS SCORE 1559233C
3047800187 GLUCOSE, SERUM GLU GLUCOSE Glucose 1559233K
3047804814 STEATOSIS GRADE STEATGR STEATOSIS GRADE 1559233D
3047805421 CHOLESTEROL, TOTAL. CHOL CHOLESTEROL, TOTAL 1559233J
3047801207 AST (SGOT) P5P AST AST SGOT P5P AST (SGOT) P5P 1559233I
3047803699 NASH GRADE NASH NASH GRADE 1559233F
3047801389 BILIRUBIN, TOTAL BILITOT BILIRUBIN TOTAL Total Bilirubin 5907810J
3047803488 METHODOLOGY (LABCORP) METHOD METHODOLOGY LABCORP 1559233T
3047805489 FIBROSIS STAGE. FIBROSIS FIBROSIS STAGE 1559233B
3047803093 INTERPRETATIONS INTERP INTERPRETATIONS 1559233M
3047805435 ADDITIONAL COMMENT:. COMMENT ADDITIONAL COMMENT 1559233S
3047805436 COMMENT:. COMMENT COMMENT 1559233R